GET THE APP

Advanced GRN Inference: Multi- Omics to Therapy
Journal of Genetics and Genomes

Journal of Genetics and Genomes

ISSN: 2684-4567

Open Access

Opinion - (2025) Volume 9, Issue 3

Advanced GRN Inference: Multi- Omics to Therapy

Ananya Deshmukh*
*Correspondence: Ananya Deshmukh, Department of Human Genome Variation, Pune Institute of Life Sciences, Pune, India, Email:
Department of Human Genome Variation, Pune Institute of Life Sciences, Pune, India

Received: 02-Jun-2025, Manuscript No. jgge-25-174478; Editor assigned: 04-Jun-2025, Pre QC No. P-174478; Reviewed: 18-Jun-2025, QC No. Q-174478; Revised: 23-Jun-2025, Manuscript No. R-174478; Published: 30-Jun-2025 , DOI: 10.37421/2684-4567.2025.9.181
Citation: Deshmukh, Ananya. ”Advanced GRN Inference: Multi-Omics to Therapy.” J Genet Genom 09 (2025):181.
Copyright: © 2025 Deshmukh A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Introduction

Understanding complex biological systems often hinges on accurately inferring gene regulatory networks. One key area of focus involves developing robust methods to infer these networks, especially when dealing with challenges like missing values within multi-omics datasets. Effectively integrating various data types and adeptly handling data incompleteness proves crucial for achieving more accurate network reconstructions, which in turn offers deeper insights into intricate biological mechanisms [1].

Beyond inference, gene regulatory networks play an intricate role in cancer progression. Comprehensive reviews delve into the molecular mechanisms underpinning these networks in cancer, aiming to identify potential therapeutic avenues. Gaining a thorough understanding of these complex networks provides valuable insights essential for developing targeted cancer treatments and ultimately improving patient outcomes [2].

The advent of single-cell multi-omics data has opened new frontiers for defining gene regulatory networks. This type of data is effectively utilized to reveal cell-type-specific regulatory interactions. The power lies in combining different single-cell data types, which allows for an unparalleled understanding of cellular heterogeneity and its implications [3].

Advancements in computational methodology are continuously enhancing network inference. For instance, GRNBoost2 represents a significant step forward as a parallel inference method specifically designed for gene regulatory networks. This method employs tree-based ensemble learning, dramatically improving the speed and scalability of network reconstruction from large transcriptomic datasets, thereby making it a practical tool for conducting complex biological investigations [4].

The dynamic interplay between epigenetic modifications and gene regulatory networks is another critical area of study. Research in this field shows how epigenetic changes can fundamentally alter the structure and function of these networks. This impact, in turn, influences gene expression and cellular identity, which are key aspects of cellular differentiation and disease progression [5].

Computational approaches are also pivotal for reconstructing gene regulatory networks from single-cell transcriptomics data, particularly for the analysis of developmental trajectories. These methods are instrumental in mapping out the precise gene interactions that guide cell fate decisions throughout development, providing clarity on complex cellular processes [6].

The landscape of gene regulatory network inference is further shaped by deep learning techniques. A comprehensive survey of these techniques highlights the significant advancements made and the ongoing challenges in using complex neural network architectures to uncover gene interactions from large-scale genomic data. This pushes the boundaries of current network reconstruction capabilities [7].

Perturbing gene regulatory networks has emerged as a powerful experimental and analytical tool, especially in the context of drug discovery and repositioning. By systematically altering network states, researchers can effectively identify novel drug targets and repurpose existing drugs for new therapeutic applications, significantly accelerating pharmacological development efforts [8].

Comparative analysis of gene regulatory networks offers profound insights into evolutionary biology. This research aims to uncover conserved and species-specific regulatory programs during mammalian brain evolution. Such analyses illuminate the genetic underpinnings of evolutionary adaptations and explain distinct brain functions observed across various species [9].

Finally, understanding plant biology, particularly complex processes like development and stress responses, heavily relies on deciphering plant gene regulatory networks. This is achieved through the application of advanced computational methods. These techniques are absolutely essential for making significant agricultural improvements and ensuring food security [10].

Description

The understanding of gene regulatory networks (GRNs) forms a cornerstone in dissecting the complexities of biological systems. A significant thrust in current research involves creating and refining robust methodologies for inferring these networks, particularly when confronting challenging scenarios such as missing values within vast multi-omics datasets. The capacity to integrate diverse data types effectively and manage data incompleteness not only leads to more accurate network reconstructions but also provides profoundly deeper insights into intricate biological mechanisms [1]. Furthermore, the emergence of single-cell multi-omics data has revolutionized our ability to precisely define cell-type-specific regulatory interactions. This powerful approach, by combining different single-cell data types, offers an unparalleled opportunity to understand cellular heterogeneity at an unprecedented resolution [3]. These advanced computational strategies extend to the crucial task of reconstructing GRNs from single-cell transcriptomics data, specifically tailored for the detailed analysis of developmental trajectories. Such methods are instrumental in meticulously mapping out the gene interactions that intricately guide cell fate decisions throughout various stages of development, thereby clarifying complex cellular processes and lineage commitments [6].

The analytical landscape of GRNs is continuously being reshaped and enhanced by sophisticated computational and machine learning methodologies. For instance, the introduction of GRNBoost2 marks a significant advancement, providing a parallel inference method specifically designed for gene regulatory networks. This innovative approach leverages tree-based ensemble learning, dramatically improving both the speed and scalability of network reconstruction when applied to large transcriptomic datasets. This efficiency makes it a highly practical tool for undertaking comprehensive and complex biological investigations that were previously resource-intensive [4]. Moreover, the application of deep learning techniques to GRN inference is rapidly expanding, with ongoing surveys highlighting both the substantial advancements already made and the persistent challenges encountered in employing complex neural network architectures to uncover subtle gene interactions from vast, large-scale genomic data. This continuous evolution actively pushes the boundaries of what is possible in network reconstruction [7]. These advanced computational techniques are not confined to human or animal models; they are equally vital for deciphering the complex plant GRNs. Understanding these networks is absolutely crucial for comprehending intricate plant biological processes, such as development and stress responses, ultimately holding significant implications for agricultural improvements and ensuring global food security [10].

The utility of GRNs extends significantly into practical applications, particularly within the realms of health and disease. Their intricate and often dysregulated role in cancer progression constitutes a major area of intensive research. Studies meticulously delve into the molecular mechanisms that underlie these networks in various cancers, with the explicit goal of identifying novel and effective therapeutic avenues. A thorough understanding of these complex networks offers critical insights that are indispensable for developing highly targeted cancer treatments, ultimately leading to improved patient outcomes and more personalized medicine approaches [2]. Furthermore, the strategic perturbation of gene regulatory networks has emerged as an exceptionally powerful experimental and analytical tool, especially within the domains of drug discovery and repositioning. By systematically altering the states of these networks, researchers are empowered to effectively identify novel drug targets that might have previously been overlooked, and to creatively repurpose existing drugs for entirely new therapeutic applications. This systematic approach significantly accelerates the process of pharmacological development, bringing new treatments to patients faster [8].

Beyond their inference and direct clinical applications, GRNs are fundamentally woven into the fabric of core biological mechanisms. The dynamic interplay between epigenetic modifications and gene regulatory networks, for example, is a testament to this deep integration. Research clearly demonstrates how epigenetic changes can fundamentally alter both the structure and function of these intricate networks. This direct impact, in turn, profoundly influences gene expression patterns and dictates cellular identity, which are key, interconnected aspects of cellular differentiation processes and the progression of various diseases [5]. Lastly, employing comparative analysis of GRNs offers a unique and invaluable lens through which to explore evolutionary biology. This research endeavors to uncover both conserved and species-specific regulatory programs that have driven mammalian brain evolution over millennia. Such detailed analyses provide profound insights into the genetic underpinnings of evolutionary adaptations and help explain the distinct brain functions and complexities observed across a diverse range of different species, highlighting the adaptability of life [9].

Conclusion

Research into gene regulatory networks (GRNs) highlights their critical role across biological domains, with significant strides in their inference and application. New methods robustly infer GRNs from multi-omics datasets, even when facing missing values, leading to more accurate network reconstructions essential for biological understanding. This work extends to clinical relevance, specifically exploring GRNs in cancer progression to identify molecular mechanisms and therapeutic opportunities. Single-cell multi-omics data are effectively leveraged to define cell-type-specific regulatory interactions, offering a deeper understanding of cellular heterogeneity and developmental trajectories. Computational innovations like GRNBoost2, which uses tree-based ensemble learning, improve the speed and scalability of network reconstruction from large transcriptomic datasets. Additionally, deep learning techniques are surveyed for their role in uncovering gene interactions from large-scale genomic data. The dynamic interplay between epigenetic modifications and GRNs reveals how these changes impact gene expression and cellular identity, which is crucial for cellular differentiation and disease processes. Perturbing GRNs proves a powerful tool in drug discovery and repositioning, helping identify novel drug targets and repurpose existing drugs. Comparative analyses of GRNs further uncover conserved and species-specific regulatory programs, as seen in mammalian brain evolution. Finally, advanced computational methods are key to deciphering plant GRNs, which is vital for understanding plant development, stress responses, and agricultural improvements.

Acknowledgement

None

Conflict of Interest

None

References

1. Xiaohui C, Yuxin L, Lu L. "Robust inference of gene regulatory networks from multi-omics data with missing values".Brief Bioinform 24 (2023):bbad433.

Indexed at, Google Scholar, Crossref

2. Jinsong L, Mengli L, Xiaoxiao K. "Deciphering Gene Regulatory Networks in Cancer: From Molecular Mechanisms to Therapeutic Opportunities".Cells 12 (2023):867.

Indexed at, Google Scholar, Crossref

3. Yichen L, Zhiyong L, Yang Z. "Leveraging single-cell multi-omics to define gene regulatory networks".Trends Biotechnol 41 (2023):1307-1323.

Indexed at, Google Scholar, Crossref

4. Bram VE, Wouter S, Pieter L. "GRNBoost2: Parallel inference of gene regulatory networks with tree-based ensemble learning".Bioinformatics 36 (2020):256-258.

Indexed at, Google Scholar, Crossref

5. Jiazhi C, Long J, Ruoqi L. "Epigenetic Regulation of Gene Regulatory Networks".Front Genet 12 (2021):642938.

Indexed at, Google Scholar, Crossref

6. Xiaoyu L, Lei W, Xiaomin Z. "Computational reconstruction of gene regulatory networks from single-cell transcriptomics for developmental trajectory analysis".Curr Opin Struct Biol 84 (2023):102607.

Indexed at, Google Scholar, Crossref

7. Zhexuan L, Yifei S, Zhenzhen X. "Deep learning for gene regulatory network inference: a survey".Brief Bioinform 25 (2024):bbae021.

Indexed at, Google Scholar, Crossref

8. Zhiheng H, Kaiwen W, Wenbo Z. "Perturbation of gene regulatory networks: a tool for drug discovery and repositioning".Front Cell Dev Biol 10 (2022):955427.

Indexed at, Google Scholar, Crossref

9. Hongjun L, Zirui H, Yi L. "Comparative analysis of gene regulatory networks identifies conserved and species-specific regulatory programs in mammalian brain evolution".Nat Commun 14 (2023):5693.

Indexed at, Google Scholar, Crossref

10. Xiaoying Z, Zhenyu L, Fengming S. "Deciphering plant gene regulatory networks using advanced computational methods".Comput Struct Biotechnol J 21 (2023):5666-5677.

Indexed at, Google Scholar, Crossref

arrow_upward arrow_upward